National Medical Products Administration (NMPA)
Is GHK-Cu (copper peptide) legal in China?
Not approvedNo NMPA drug approval found for GHK-Cu; it cannot lawfully be sold as a medicine in China.
Not approved as a medicine here.
We found no NMPA drug approval and no application for GHK-Cu (copper peptide) in CDE's public register. Selling it as an injectable or other medicine would need a marketing approval under Article 98 of the Drug Administration Law, and hospital preparations cannot be sold on the market. This record covers medicines only; cosmetic ingredients are regulated separately and were not reviewed here.
Last verified 2026-09-29 · how we verify
GHK-Cu (copper peptide) elsewhere
Sources (3)
- 01Drug Administration Law of the PRC (中华人民共和国药品管理法)National Medical Products Administration (NMPA) · 2019-08-26 · accessed 2026-09-29
- 02CDE public register of accepted drug applications (受理品种目录浏览)Center for Drug Evaluation (CDE), NMPA · 2026-09-29 · accessed 2026-09-29
- 03Provisions for Drug Registration (SAMR Order No. 27; 药品注册管理办法)State Administration for Market Regulation (SAMR) · 2020-01-22 · accessed 2026-09-29